Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of "Hold" by Analysts

Key Points

• Sonova Holding has received a consensus recommendation of "Hold" from ten research firms, with varying ratings among analysts.
• The company's stock is currently trading at $55.34 with a fifty-two week range from $52.83 to $77.56.
• Recent analyst upgrades include a transition from "strong sell" to "hold", and "hold" to "strong-buy" from different firms.

Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) have earned a consensus recommendation of "Hold" from the ten research firms that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a strong buy recommendation to the company.

Several equities analysts recently weighed in on the company. Rothschild Redb upgraded Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Zacks Research upgraded Sonova from a "hold" rating to a "strong-buy" rating in a research note on Thursday, October 16th. BNP Paribas assumed coverage on Sonova in a research note on Monday. They issued an "underperform" rating for the company. Finally, Sanford C. Bernstein upgraded Sonova from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 18th.

Sonova Trading Up 0.6%

OTCMKTS SONVY opened at $55.34 on Tuesday. The stock has a 50-day simple moving average of $57.05 and a two-hundred day simple moving average of $58.85. Sonova has a fifty-two week low of $52.83 and a fifty-two week high of $77.56. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.45.

Sonova Company Profile

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.